Uncategorised – Page 38 – Market Industry Forecast News

Nerve Repair And Regeneration Market Key Players: Polyganics B.V., Boston Scientific, Inc., Cyberonics, Inc., Medtronic Plc

Nerve Repair and Regeneration Industry Overview

The global nerve repair and regeneration market size was valued at USD 6.8 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 12.16% from 2022 to 2030. Rising cases of neurological disorders and a strong product pipeline by the major companies are the key factors driving the market. Improved treatment efficiency for neurological disorders due to several technological advancements is also likely to contribute to the market growth.

During the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, various government containment measures led outpatient clinics’ neurological activities to be disrupted. Vulnerable patients such as those with Parkinson’s disease (PD) or dystonic patients with deep brain stimulation (DBS) were at a higher risk of chronic stress as a result of social restriction measures, and their motor and psychiatric symptoms were reported to deteriorate.

Gather more insights about the market drivers, restrains and growth of the Global Nerve Repair and Regeneration market

Furthermore, the availability of multiple therapies for treating various Central Nervous System (CNS) disorders, such as Parkinson’s disease and Alzheimer’s, and the increasing scope of applications are further expected to boost the market growth over the forecast period. According to the Alzheimer’s Association, in 2022, 6.5 million people aged 65 or more in America were suffering from Alzheimer’s disease.

Increasing awareness, environmental influence, lifestyle, genetics, nutrition, and physical injuries are some of the factors that can cause such disorders. In 2015, a report presented at the annual meeting of the American Society for Surgery of the Hand (ASSH) stated that the processed nerve allograft used in the treatment of patients with upper extremity nerve impairments may lead to the restoration of motor and sensory nerve functions. Patients treated with a PNA allograft (Avance Nerve Graft, AxoGen) exhibited recovery of motor function and sensory nerve function in 75% and 85% of the patients, respectively.

Browse through Grand View Research’s Medical Devices Industry Research Reports.

Laparotomy Sponge Market – The global laparotomy sponge market size was valued at USD 713.5 million in 2016. Rising geriatric population, increasing prevalence of chronic diseases due to changing lifestyles, and growing incidence of abdominal diseases are among key trends augmenting the market.
Microelectronic Medical Implants Market – The global microelectronic medical implants market size was valued at USD 24.80 billion in 2016 and is expected to develop at a CAGR of 9.8% during the forecast period.

Nerve Repair And Regeneration Market Segmentation

Grand View Research has segmented the global nerve repair and regeneration market on the basis of product, surgery, and region:

Nerve Repair and Regeneration Product Outlook (Revenue, USD Million, 2018 – 2030)

Biomaterials
Neurostimulation and Neuromodulation Devices
- Spinal Cord Stimulation Devices
- Deep Brain Stimulation Devices
- Sacral Nerve Stimulation Devices
- Vagus Nerve Stimulation Devices
- Gastric Electric Stimulation Devices

Nerve Repair and Regeneration Surgery Outlook (Revenue, USD Million, 2018 – 2030)

Direct Nerve Repair/Neurorrhaphy
Nerve Grafting
Stem Cell Therapy
Neurostimulation and Neuromodulation Surgeries

Nerve Repair and Regeneration Regional Outlook (Revenue, USD Million, 2018 – 2030)

North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)

Market Share Insights

January 2018: Boston Scientific Corporation announced positive results from the randomized controlled trial – WHISPER.
June 2016: St. Jude Medical launched direction DBS lead and Infinity DBS system to support treatments pertaining to movement disorders.

Key Companies profiled:

Some prominent players in the global nerve repair and regeneration market include:

AxoGen, Inc.
Stryker Corporation
St. Jude Medical, Inc.
Baxter International, Inc.
Polyganics B.V.
Boston Scientific, Inc.
Integra Lifesciences Corporation
Cyberonics, Inc.
Medtronic plc.

Order a free sample PDF of the Nerve Repair and Regeneration Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Assisted Walking Devices Market Key Players: Benmor Medical, Briggs Healthcare, Carex Health Brands, And TOPRO

Assisted Walking Device Industry Overview

The global assisted walking devices market size was valued at USD 3.4 billion in 2021 and is anticipated to expand at a compound annual growth rate (CAGR) of 6.6% during the forecast period. Key factors attributed to the growth are the overwhelming geriatric population figures, rise in prevalence of target diseases, such as arthritis, and Parkinson’s disease, and rise in the total number of surgical operations globally. Furthermore, financial support and initiatives undertaken by government and private organizations to encourage the use of assistive mobility devices are expected to boost the market growth.

The COVID-19 pandemic has significantly impacted the market. During the pandemic, the manufacturing of assisted walking devices was halted due to a stay-at-home order by the government. It has led to a disoriented supply chain. In addition, due to limited financial resources, there is less investment in the research and development of assisted walking devices. However, the market has shown slight growth in the second half of 2020 and is expected to grow post-pandemic as well due to a rise in the prevalence of diseases such as obesity, which occurred due to inactivity and isolation during the pandemic. The rise in this has led to the use of walking devices by bariatric patients.

Gather more insights about the market drivers, restrains and growth of the Global Assisted Walking Device market

The increased prevalence of target diseases including Rheumatoid Arthritis and Parkinson’s disease is expected to propel the usage rates of assisted walking devices during the forecast period. The rise in the total number of surgical operations creates a high demand for assisted walking devices as they are employed in rehabilitation programs to gradually restore body balance and promote muscle functioning in sedentary, handicapped individuals.

Initiatives hosted by government and private organizations provide access to equipment demonstrations at centers that furnish patients with relevant advice related to making an equipment choice suited to a specific disability. Additionally, patients with chronic illnesses or long-standing disabilities are exempted from paying VAT on mobility products. The governments of the countries, the U.S., and the U.K. offer special grants to physically-handicapped patients to purchase this equipment. Independent organizations including Charity search, Disablement Information, and Advice Lines (DIAL) network, Rica, and Shop mobility are actively engaged in providing varied services for the physically disabled seeking solutions. The World Health Organization (WHO) has declared the Priority Assistive Products List, which has been published to promote equitable access to assistive mobility devices to those in need, and further, the list serves to outline reimbursement policies and provide guidance in matters related to purchasing these devices.

Browse through Grand View Research’s Medical Devices Industry Research Reports.

Scanning Electron Microscopes Market – The global scanning electron microscopes market size was valued at USD 3.4 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 8.52% from 2021 to 2028.
Refractive Surgery Devices Market – The global refractive surgery devices market size was valued at USD 168.2 million in 2020 and is expected to expand at a compound annual growth (CAGR) of 7.7% from 2021 to 2028.

Assisted Walking Devices Market Segmentation

Grand View Research has segmented the assisted walking devices based on product type, distribution channel, end-User and region:

Assisted Walking Devices Product Type Outlook (Revenue, USD Million, 2018 – 2030)

Canes
Crutches
Walkers
Gait Trainers

Assisted Walking Devices Distribution Channel Outlook (Revenue, USD Million, 2018 – 2030)

Online
Offline

Assisted Walking Devices End-User Outlook (Revenue, USD Million, 2018 – 2030)

Hospitals
Non-Hospitals

Assisted Walking Devices Regional Outlook (Revenue, USD Million, 2018 – 2030)

North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)

Market Share Insights

February 2021: Invacare Corporation announces the launch of Invacare® AVIVA® STORM RX™ power wheelchair.

Key Companies profiled:

Some of the prominent players operating in the global assisted walking devices market include:

Medline Industries Karman,
Benmor Medical,
Briggs Healthcare,
Carex Health Brands,
TOPRO,
Invacare Corporation,
Drive medical design,
Eurovema AB
HUMAN CARE

Order a free sample PDF of the Assisted Walking Device Market Intelligence Study, published by Grand View Research.

About Grand View Research

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Connected Health And Wellness Solutions Market: Asia Pacific is anticipated to grow at the fastest CAGR from 2022 to 2030

Connected Health And Wellness Solutions Industry Overview

The global connected health and wellness solutions market size was valued at USD 35.30 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 20.6% from 2022 to 2030. An increasing number of individuals afflicted with chronic illnesses create the demand for disease management & continuous patient monitoring tools, thereby boosting the demand for connected health devices. These devices are connected to electronic patient health records and provide access to the required health information during the course of the treatment. Technology is bringing down medical costs and increasing accessibility to more individuals. High-speed internet and favorable government initiatives have also contributed to the rapid growth of the market. Personalized healthcare can offer solutions to chronic health problems.

In September 2020, Roche launched a remote patient monitoring solution that enables healthcare professionals to oversee individuals with diabetes outside of the care setting. The COVID-19 pandemic has positively impacted market growth. This is owing to the upsurge in the number of patients, the burden on healthcare providers to offer innovative healthcare services, and governments’ efforts for progressing apps based on connectivity technologies. The COVID-19 pandemic has carried out innovative ways for doctor-patient interaction. The pandemic pushed the adoption and use of numerous technologies like e-prescription, telemedicine, and so on among healthcare providers and patients

Gather more insights about the market drivers, restrains and growth of the Global Connected Health And Wellness Solutions market

There is a growing trend of telemedicine services as governments around the globe restricted citizens to avoid movement outside their homes. As the whole concentration of hospitals is on treating COVID-19 patients, individuals are discovering new ways to monitor their health and only approach doctors in case of emergencies. Thus, the sales of smart wearables, specifically, smartwatches, have improved in the last few months. The pandemic could lead to a permanent development in the practice of numerous connected healthcare products and services. The COVID-19 pandemic has significantly influenced many corporations to implement and update new technology and put the groundwork for a novel standard of care.

For instance, in November 2020, Garmin International, Inc., publicized pregnancy tracking, offering mothers-to-be a snapshot of their pregnancy together with their other health, wellness, and activity data. Mass adoption of mHealth devices and the introduction of technologically advanced product designs are anticipated to drive the market over the forecast period. The focused approach toward the adoption of Internet of Things (IoT) devices and wearable medical devices, which include sensors and mobile communication devices, is also expected to drive the industry’s growth. Moreover, the increased emphasis on the reduction of the skyrocketing healthcare costs and the rising awareness levels pertaining to connected health devices are pushing the healthcare system to incorporate innovative strategies to meet the high patient volumes thus, driving the market.

Browse through Grand View Research’s Healthcare IT Industry Research Reports.

Medical Image Analysis Software Market – The global medical image analysis software market size was valued at USD 2.90 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 7.5% over the forecast period.
eHealth Market – The global eHealth market size was valued at USD 204.32 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 17.4% from 2022 to 2030.

Connected Health And Wellness Solutions Market Segmentation

Grand View Research has segmented the global connected health and wellness solutions market by product, application, function, end user, and region:

Connected Health & Wellness Solutions Product Outlook (Revenue, USD Million, 2017 – 2030)

Personal Medical Devices
- Insulin Pump
- BP Monitor
- Glucose Monitor
- Personal Pulse Oximeter
- Others
Wellness Products
- Digital Pedometer
- Body Analyzer
- Heart Rate Monitor
- Sleep Quality Monitor
- Others
Software & Services
- Online Subscription
- Fitness & Wellness App
- Others

Connected Health & Wellness Solutions Function Outlook (Revenue, USD Million, 2017 – 2030)

Clinical Monitoring
Telehealth

Connected Health & Wellness Solutions Application Outlook (Revenue, USD Million, 2017 – 2030)

Diagnosis & Treatment
Wellness & Prevention
Monitoring
Others

Connected Health &Wellness Solutions End-user Outlook (Revenue, USD Million, 2017 – 2030)

Hospitals & Clinics
Home Monitoring

Connected Health & Wellness Solutions Regional Outlook (Revenue, USD Million, 2017 – 2030)

North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)

Market Share Insights

July 2020: OMRON Healthcare, Inc. collaborated with Mount Sinai Health System. This collaboration helped patients with high risk to monitor their blood pressure from Home with VitalSight.
March 2020: Fitbit LLC launched Fitbit Charge 4, an advanced health & fitness tracker with built-in GPS, sleep tools, Active Zone Minutes, Spotify, Fitbit Pay, and others.

Key Companies profiled:

Some prominent players in the global connected health and wellness solutions market include:

Omron Healthcare, Inc.
Koninklijke Philips N.V.
GE Healthcare
Drägerwerk AG & Co. KGaA
Fitbit LLC
Medtronic
Abbott
Boston Scientific Corp.
Garmin International, Inc.
Apple, Inc.
Masimo Corp.
ResMed
NXGN Management, LLC
Letscom
Senseonics, Inc.

Order a free sample PDF of the Connected Health And Wellness Solutions Market Intelligence Study, published by Grand View Research.

About Grand View Research

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Parenteral Nutrition Market Is Expected To Expand At A CAGR Of 6.0% Over The Forecast Period

Parenteral Nutrition Industry Overview

The global parenteral nutrition market size was valued at USD 6.4 billion in 2021 and is projected to grow at a compound annual growth rate (CAGR) of 6.0% from 2022 to 2030. Development of technically advanced parenteral nutrition products with barcode assistance, growing preference for parenteral nutrition over enteral nutrition in patients with COVID-19, shorter hospital stays, along with the reduced risk of infection are factors expected to boost the product demand, thereby driving the market. According to the ASPEN20 Virtual Conference, providing appropriate nutrition to adults with COVID-19 remains a priority for optimizing outcomes. This includes overcoming various challenges amid the pandemic, such as a shortage of parenteral nutrition products due to a disrupted supply chain.

Moreover, the increasing prevalence of chronic conditions, majorly cancer & malnutrition, and the rapidly growing geriatric population and natality incidence are key high impact-rendering drivers for market growth. Increasing natality is expected to be another major market driver. Various benefits associated with parenteral nutrition cover easy usage, stimulating stomach blood flow, providing efficient nutrients, and preserving muscle catabolism. An increase in awareness about these benefits is likely to help boost the product demand. For instance, educational campaigns pertaining to health awareness particularly emphasizing nutrition and various initiatives have been undertaken to promote health & social care.

Gather more insights about the market drivers, restrains and growth of the Global Parenteral Nutrition market

PN can be given to children and infants suffering from a disease or medical condition, thereby requiring special nutritional management. Specialized Nutrition Europe (SNE) estimated that nearly 300,000 EU children are anticipated to require medical nutrition for their special medical needs in early life stages, which supports growth and development. The study further reveals that about 40% of the hospitalized adult patients are malnourished and need medical nutrition to manage the disease-related malnutrition condition, thereby reducing the duration of hospital stay. Parenteral nutrition further lowers the infection risk and underdevelopment, thereby promoting its adoption worldwide.

Most of the premature babies suffer from low weight and undeveloped immunity, which puts them at risk. In addition, individuals and healthcare authorities are extensively focusing on limiting mortality due to early birth, thereby driving the use of parenteral lipid emulsions. In 2016, the premature birth rate in the U.S. was about 9.6% and national authorities are working toward reducing it to 8.1%, according to the National Center for Healthcare Statistics. Moreover, a rise in the number of hospitalizations for COVID-19 patients during this pandemic further boosted the product adoption in various hospitals, clinics, and Ambulatory Surgical Centers (ASCs).

Changing reimbursement scenarios coupled with other emerging trends to facilitate product adoption are projected to boost market growth in the near future. Various health plans are now available in the U.S. to cope with the problems caused by the COVID-19 pandemic. The immediate implementation of reforms in the Value-based Insurance Design (V-BID) model by the Centers for Medicare & Medicaid Services (CMS) ensures affordable and easy access to critical, clinical services. Thus, the COVID-19 pandemic is anticipated to positively impact the market and boost product adoption in the coming years.

Furthermore, the increasing prevalence of chronic conditions, such as cancer, is positively impacting the product usage worldwide. Parenteral nutrition helps in the administration of vital nutrients, which helps in maintaining strength, energy, and hydration levels in patients suffering from cancer at all stages, i.e., from diagnosis to recovery. According to the WHO, approximately 8.2 million deaths are recorded each year due to cancer, accounting for 13.0% of deaths worldwide. Moreover, there is expected to be a 70.0% increase in new cases of cancer in the next couple of decades. Thus, the increasing prevalence of cancer is one of the key factors contributing to the market growth.

Browse through Grand View Research’s Pharmaceuticals Industry Research Reports.

Influenza Vaccine Market -The global influenza vaccine market size was valued at USD 7.28 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 6.83% from 2023 to 2030.
Population Screening Market – The global population screening market was estimated at USD 25.18 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 5.36% from 2023 to 2030.

Parenteral Nutrition Market Segmentation

Grand View Research, Inc. has segmented the global parenteral nutrition market on the basis of nutrient type and region:

Parenteral Nutrition Nutrient Type Outlook (Revenue, USD Million, 2016 – 2030)

Carbohydrates
Parenteral Lipid Emulsion
Single Dose Amino Acid Solution
Trace Elements
Vitamins & Minerals

Parenteral Nutrition Regional Outlook (Revenue, USD Million, 2016 – 2030)

North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)

Market Share Insights

January 2020: Fresenius Kabi completed its clinical trial for SmofKabiven. SmofKabiven is their new launch in the range of lipid emulsions. It is made of multiple oils (fish, soybean, & olive oils, and medium-chain triglycerides) along with a separate chamber for amino acids, glucose, and lipids.

Key Companies profiled:

Some of the key players operating in the global parenteral nutrition market are:

Baxter
Allergan
Actavis Inc.
Otsuka Pharmaceutical Factory, Inc.
Grifols, S.A.
B. Braun Melsungen AG
Vifor Pharma
Fresenius Kabi AG
Sichuan Kelun Pharmaceutical Co., Ltd.
Pfizer Inc. (Hospira Inc.)

Order a free sample PDF of the Parenteral Nutrition Market Intelligence Study, published by Grand View Research.

About Grand View Research

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Ultrasound Device Market Is Anticipated To Expand At A CAGR Of 4.5% From 2022 To 2030

Ultrasound Device Industry Overview

The global ultrasound device market size was valued at USD 7.9 billion in 2021 and is anticipated to expand at a CAGR of 4.5% from 2022 to 2030. The rise in the adoption of ultrasound devices for diagnostic imaging and treatment, coupled with the increasing incidences of chronic and lifestyle-related disorders, is expected to boost the market growth. In addition, the rising demand for minimally invasive surgery and technological advancements in ultrasound imaging technology are some of the key factors driving the market. Ultrasound is considered one of the most valuable diagnostic tools in medical imaging due to the fact that it is fast and less expensive. In addition, it is safer than other imaging technologies as it does not utilize ionizing radiation and magnetic field.

The ultrasonic medical device has a wide range of diagnostic as well as therapeutic applications. Ultrasonography has become more popular for specific therapeutic applications, ranging from cardiology to oncology. The expansion of ultrasound device applications in 3D imaging, shear wave elastography, development of wireless transducers, app-based ultrasound technology, fusion with CT/MR, and laparoscopic ultrasound is set to keep the market excited for the near future. For instance, Samsung Medison collaborated with Intel for NerveTrack, a real-time nerve tracking ultrasonography technology that helps anesthesiologists detect nerves in a patient’s arm and deliver anesthesia swiftly and precisely.

Gather more insights about the market drivers, restrains and growth of the Global Ultrasound Device market

Furthermore, the integration of artificial intelligence (Al) to automate time-consuming processes such as quantification and selecting the best image slice from a 3-D dataset is expected to boost the market growth. Many high-end ultrasound systems now use AI, and most new systems at all levels are expected to include AI in the future. The healthcare system had faced enormous difficulties as a result of the COVID-19 pandemic. The demand for ultrasound devices was uneven during the pandemic as there were postponements in installations and a drop in manufacturing was also observed. Manufacturers had to focus on COVID essential device manufacturing and COVID tackling methods such as telehealth services, vaccination drives for employees, and others. However, the handheld ultrasound device was in high demand owing to its efficiency in treating critical care patients in crowded hospitals because of the systems’ speed, portability, and ease of use.

Browse through Grand View Research’s Medical Imaging Industry Research Reports.

Dermatology Imaging Market – The visual nature of dermatology has made imaging techniques a highly essential part of assessing and treating cutaneous diseases. Imaging is mainly used for documenting conditions, monitoring high-risk patients, communicating and academics.

Medical Imaging Market – The global medical imaging market size was valued at USD 28.02 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 4.9% from 2022 to 2030.

Ultrasound Device Market Segmentation

Grand View Research has segmented the global ultrasound device market based on product, portability, application, end-use, and region:

Ultrasound Devices Product Outlook (Revenue, USD Million, 2018 – 2030)

Diagnostic Ultrasound Devices
- 2D
- 3D/4D
- Doppler
Therapeutic Ultrasound Devices
- High-intensity Focused Ultrasound
- Extracorporeal Shockwave Lithotripsy

Ultrasound Devices Portability Outlook (Revenue, USD Million, 2018 – 2030)

Handheld
Cart/Trolley

Ultrasound Devices Application Outlook (Revenue, USD Million, 2018 – 2030)

Cardiology
Obstetrics/Gynaecology
Vascular
Orthopedic
General Imaging

Ultrasound Devices End-use Outlook (Revenue, USD Million, 2018 – 2030)

Hospitals
Imaging Centres
Research Centres

Ultrasound Devices Regional Outlook (Revenue, USD Million, 2018 – 2030)

North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)

Market Share Insights

March 2021: GE Healthcare introduced Vscan Air, a wireless pocket-sized ultrasound that gives crystal clear image quality, whole-body scanning capability, and intuitive software, all in the palm of clinicians’ hands.

Key Companies profiled:

Some of the prominent players in the global ultrasound device market include:

Koninklijke Philips N.V.
GE Healthcare
Siemens Healthineers AG
Canon Medical Systems
Mindray Medical International Limited
Samsung Medison Co., Ltd.
FUJIFILM SonoSite, Inc.
Konica Minolta Inc.
Esaote

Order a free sample PDF of the Ultrasound Device Market Intelligence Study, published by Grand View Research.

About Grand View Research

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Surgical Robots Market Key Players: Intuitive Surgical, Medtronic, THINK Surgical Inc., Zimmer Biomet

Surgical Robots Industry Overview

The global surgical robots market size was valued at USD 4.4 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 18.0% from 2023 to 2030. The shortage of physicians and surgeons all over the globe and the increasing adoption of automated instruments used for surgery are the major factors driving the market. The increasing investments by the regional and international players in the introduction of new and technologically advanced surgical robots are also positively impacting the market growth.

Furthermore, the growing prevalence of bone degenerative diseases and the rising number of hip and knee replacement surgeries due to the increasing cases of arthritis and osteoporosis are the major factors anticipated to fuel the market growth. For instance, according to the Agency for Healthcare Research and Quality report, over 4,50,000 hip replacement surgeries are performed each year in the U.S. In addition, as per the Australian Institute of Health and Welfare (AIHW) statistics, the total knee replacement rate for osteoarthritis has been increased by about 38% from 2005-2006 to 2017-2018.

Gather more insights about the market drivers, restrains and growth of the Global Surgical Robots market

In addition, increasing regulatory approvals for the robots used in surgery is one of the prominent factors aiding the market growth. For example, in 2019, Intuitive Surgical Inc’s Ion robotic surgical system received 510(k) FDA clearance. Moreover, the growing adoption of assisted surgeries like hysterectomies, the increasing number of robotic systems for surgical interventions, and constant investments and R&D activities with respect to automated robotic systems by the manufacturers are the key factors supporting the market growth.

Furthermore, several industrial strategic initiatives by top international players are anticipated to accelerate the market growth over the years. For instance, in 2019, Ethicon, a subsidiary of Johnson & Johnson, acquired Auris Health, which is a developer of a robotic technology platform. This acquisition is aimed at supporting the expansion of Ethion’s digital surgery portfolio to combat lung cancer. In addition, Stryker corporation, in 2019, acquired OrthoSpace, Ltd., which has helped in increasing the company’s surgical equipment portfolio. Therefore, such industrial initiatives are expected to propel the adoption of robots and the growth of the market.

The technological advancements in the field of automated medical instruments such as the combination of cameras, high-definition 3D imaging, computing technology, sensors, remote navigation technology systems, robotic controlled catheters, and other accessories utilized for medical surgeries are also increasing the adoption of automated instruments, which is further anticipated to drive the market over the forecast years.

Moreover, complications associated with automated robotic surgery such as possible inadvertent cuts, loss of a large amount of blood, tears, burns, punctures, or other injuries to organs, and the high cost of the instruments may hamper the adoption of the instruments. However, advancements in technology and betterments in robotic equipment would help in reducing the errors and can lead to better outcomes and accelerate the market growth over the forecast period.

Browse through Grand View Research’s Medical Devices Industry Research Reports.

Rhinoplasty Market – The global rhinoplasty market size was valued at USD 5.1 billion in 2021 and is projected to grow at a compound annual growth rate (CAGR) of 8.9% during the forecast period.

Medical Oxygen Cylinders Market – The global medical oxygen cylinders market size was valued at USD 4.0 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 4.40% from 2023 to 2030.

Surgical Robots Market Segmentation

Grand View Research has segmented the global surgical robots market based on application and region:

Surgical Robots Application Outlook (Revenue, USD Million, 2016 – 2030)

Orthopedics
- Knee
- Hip
- Spine
- Others
Neurology
Urology
Gynecology
Others

Surgical Robots Regional Outlook (Volume, Units; Revenue, USD Million, 2016 – 2030)

North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)

Market Share Insights

February 2021: Medtronic acquired Digital Surgery, which is a privately-owned surgical AI company specializing in digital education, data analytics, and training.

Key Companies profiled:

Some prominent players in the global surgical robots market include:

Stryker Corporation
Medrobotics
Smith & Nephew
TransEnterix Surgical, Inc.
Renishaw plc.
Intuitive Surgical
Medtronic
THINK Surgical, Inc.
Zimmer Biomet

Order a free sample PDF of the Surgical Robots Market Intelligence Study, published by Grand View Research.

About Grand View Research

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Malaria Diagnostics Market: Asian Region Is Also Expected To Grow Along With The African Region At A CAGR

Malaria Diagnostics Industry Overview

The global malaria diagnostics market size was valued at USD 728.8 million in 2021 and is anticipated to witness a CAGR of 5.4% during the forecast period. The rising demand for malaria diagnostics and the introduction of novel diagnostic techniques are the key factors driving the market. Malaria is one of the most widespread life-threatening diseases, commonly occurring in tropical and subtropical regions due to changing climate, low economic growth, underdeveloped healthcare infrastructure, and lack of access to advanced treatment. The tropical disease caused by the female Anopheles mosquito, infected by the Plasmodium species caused over 4,35,000 deaths globally in 2017, as stated by the World Health Organization (WHO). Statistics from the same source indicate that over 219 million cases of malaria were recorded globally, with over 92% of cases being reported from Africa, 6% from South East Asia, and 2% from the Eastern Mediterranean regions. Thus, rising disease incidence is also anticipated to boost the growth of the market for malaria diagnostics in the future.

Gather more insights about the market drivers, restrains and growth of the Global Malaria Diagnostics market

In Africa, non-governmental and governmental organizations announced initiatives to support the COVID-19 research and control program. The Global Fund to Fight AIDS, Tuberculosis, and Malaria permitted receivers to use funds from already existing grants in order to control COVID-19. Efforts were taken to minimize and control the spread of the COVID-19 virus, to avoid situations that arose during the Ebola outbreak, where millions of Malaria cases were left untreated due to the severity of the Ebola virus. These were some of the factors driving the market for malaria diagnostics during the COVID-19 pandemic.

It is one of the leading causes of death in many African, Asian, and Latin American countries, such as Uganda, the Democratic Republic of Congo, Columbia, Peru, and India. Malaria during pregnancy can cause low birth weights, stillbirths, and congenital infection. Technological advancements are also expected to be one of the key drivers for the market for malaria diagnostics. Increasing demand and rising need for high-quality and cost-efficient diagnostic methods are likely to trigger advancements that can offer improved access to diagnostics, especially in remote areas. Heavy investments by government bodies and private investors to curb the disease prevalence is also one of the major factors driving the market for malaria diagnostics. According to the data published by WHO, in 2017, approximately USD 3.1 billion were invested in the control and elimination of the disease by private international investors and government authorities of endemic nations. Over 312 million rapid diagnostic tests were delivered globally, mostly in the WHO African region, which is the worst affected region.

Browse through Grand View Research’s Clinical Diagnostics Industry Research Reports.

Anatomic Pathology Market – The global anatomic pathology market size was valued at USD 16.06 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 10.08% from 2021 to 2028.

C-reactive Protein Testing Market – The global C-reactive protein testing market size was valued at USD 5.5 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 0.3% from 2021 to 2028.

Malaria Diagnostics Market Segmentation

Grand View Research has segmented the global malaria diagnostics market on the basis of technology and region:

Malaria Diagnostics Technology Outlook (Revenue, USD Million, 2017 – 2030)

Microscopy
Rapid Diagnostic Tests (RDTs)
Molecular Diagnostic Tests
- Conventional PCR
- Real-Time PCR (qPCR)

Malaria Diagnostics Regional Outlook (Revenue, USD Million, 2017 – 2030)

North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)

Key Companies profiled:

Some of the prominent players in the malaria diagnostics market include:

Access Bio., Inc.
Abbott Laboratories
Premier Medical Corporation Pvt. Ltd.
Sysmex Partec GmbH
bioMérieux
Beckman Coulter, Inc.
Siemens Healthineers
Leica Microsystems GmbH
Nikon Corporation
Olympus Corporation
Bio-Rad Laboratories, Inc.

Order a free sample PDF of the Malaria Diagnostics Market Intelligence Study, published by Grand View Research.

About Grand View Research

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Cardiovascular and Soft Tissue Repair Patches Market Key Players: Novomedics, TEI Biosciences Inc., Perouse Medical, and Gunze Limited

Cardiovascular And Soft Tissue Repair Patches Industry Overview

The global cardiovascular and soft tissue repair patches market size was estimated at USD 3.8 billion in 2021 and is expected to expand at a CAGR of 8.4% from 2022 to 2030. The rapidly rising incidence rate of congenital heart diseases across the globe is driving the development & growth of the market. As per data estimates on congenital heart diseases published by the Centers for Disease Control and Prevention, congenital heart diseases impact nearly 1% or 40,000 live births annually in the U.S. Atrial Septal Defect (ASD) and ventricular septal defect are the two commonest congenital heart diseases.

According to an article on trends and prevalence of atrial septal defect published by NCBI in December 2019, it stated ASD is the second most occurring type of congenital heart disease and the incidence rate is 56 per 100,000 live births across the globe, and the prevalence of the same is 1.6 per 1,000 live births. The growing awareness levels towards diagnosing & detecting congenital heart diseases early is driving key players to focus on innovation & develop technologically advanced products. These technological innovations have a multidimensional impact on product design, development, raw material fabrication, and clinical implementation. The tissue repair patches used in surgical procedures include vascular repair and reconstruction, soft tissue repairs, and dural repairs.

Gather more insights about the market drivers, restrains and growth of the Global Cardiovascular And Soft Tissue Repair Patches market

The growing prevalence of hernias, including inguinal hernias, ventral hernias, congenital diaphragmatic hernias, umbilical hernias, and others, is expected to drive the demand and positively impact growth. As per studies, abdominal wall hernias are the most commonly occurring hernias and have a prevalence rate of 1.7% across all ages and 4% across populations aged 45 years and above. Inguinal hernias are the most commonly diagnosed abdominal wall hernias accounting for 75% of the total caseload. Inguinal hernia repairs are common, and the U.S. recorded an incidence rate of 28 per 100,000 individuals, while the U.K. recorded 10 per 100,000 individuals.

According to the University of California San Francisco Department of Surgery, in the U.S. annually a million-hernia repair surgical procedures are performed of which 800,000 are inguinal hernia repair procedures, and the rest are performed for treating other types of hernias.

The growing demand for patches in diagnosing and treating cardiac and soft tissue ailments is driving the collaborative efforts amongst several research organizations, raw material suppliers, and key manufacturers to develop innovative products. Furthermore, key participants are focusing on developing novel technologies composed of tissue engineering materials, which is expected to boost the growth of the market for cardiovascular and soft tissue repair patches.

For instance, a research team from Israel-based Tel Aviv University has developed a bionic heart patch by combining an organic living tissue with a nanoelectronic system, and this product could be used in supporting patients’ recovery from heart attacks. The growing demand is boosting public-private partnerships across several regional markets to boost development and growth. For instance, governments are undertaking initiatives to enhance affordability and accessibility to cardiac treatment options which is expected to support growth. For example, the Japanese government provided favorable support and recognition to the collaboration between Osaka Medical College and Teijin Limited, and Fukui Warp Knitting Co. Ltd. developing regenerative cardiac repair patches. Governments are beginning to provide favorable support and promote collaborations amongst medical and industrial players.

Browse through Grand View Research’s Medical Devices Industry Research Reports.

Procedure Trays Market – The global procedure trays market size was valued at USD 15.99 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 11.3% from 2022 to 2030.
Hospital Gowns Market – The global hospital gowns market size was valued at USD 4.3 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 12.88% from 2022 to 2030.

Cardiovascular And Soft Tissue Repair Patches Market Segmentation

Grand View Research has segmented the global cardiovascular and soft tissue repair patches market on the basis of application, raw material, and region:

Cardiovascular And Soft Tissue Repair Patches Application Outlook (Revenue, USD Million, 2016 – 2030)

Cardiac repair
- Atrial Septal Defect
- Common Atrium
- Defects of the Endocardial Cushion
- Ventricular Septal Defect
- Tetralogy of Fallot
- Right Ventricular Outflow Tract Reconstruction
- Suture bleeding
Vascular repair & reconstruction
- Carotid endarterectomy
- Anomalous Connection of the Pulmonary Veins
- Transposition of the Great Vessels
- Reconstruction of Portal and Superior Mesenteric Veins
- Other Vascular Repair and Reconstruction
Pericardial repair
Dural repair
Soft tissue repair
- Defects of the Abdominal Wall
- Defects of the Thoracic Wall
- Gastric Binding
- Hernias

Cardiovascular And Soft Tissue Repair Patches Raw Material Outlook (Revenue, USD Million, 2016 – 2030)

ePTFE
Biomaterial and tissue-engineered material
Others

Cardiovascular And Soft Tissue Repair Patches Regional Outlook (Revenue, USD Million, 2016 – 2030)

North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)

Market Share Insights

February 2020: Terumo Cardiovascular launched its latest surgical sealant, AQUABRID used in aorta surgical procedures.
December 2019: CryoLife and Misonix entered a strategic alliance wherein CryoLife’s NeoPatch would receive special commercialization rights in the U.S market.

Key Companies profiled:

Some of the prominent players in the cardiovascular and soft tissue repair patches market include:

Baxter
Admedus
Abbott
LeMaitre Vascular Inc.
Edwards Life Sciences Corporation
Glycar SA Pty Ltd.
LabCor
Cryolife, Inc.
CorMatrix
Terumo Medical Corporation
Bard Peripheral Vascular Inc.
Neovasc
W.L. Gore & Associates, Inc.
B.Braun
Novomedics
TEI Biosciences Inc.
Perouse Medical
Gunze Limited
Atriummed
Maverick Bioscience
Southern Lights Biomaterials
Integra LifeSciences Corporation

Order a free sample PDF of the Cardiovascular And Soft Tissue Repair Patches Market Intelligence Study, published by Grand View Research.

About Grand View Research

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Practice Management System Market Size Is Expected To Reach USD 28.17 Billion By 2030

Practice Management System Industry Overview

The global practice management system market size was valued at USD 12.9 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 8.8% from 2022 to 2030. The growing adoption of these management systems can be attributed to its increasing need for reduction in healthcare costs along with the ability to generate sufficient income for healthcare professionals. Furthermore, favorable initiatives undertaken by the government coupled with increasing penetration of IT in the healthcare sector are expected to fuel the market growth. For instance, in May 2020, the federal government proposed the Federal IT Strategic Plan 2020-2025, which focuses on improvising the access, exchange, and usage of electronic health information.

Practice management system vendors and organizations have initiated to help in curbing the pandemic by making telehealth a mainstream alternative, enhancing data access through EHRs, and scheduling patient appointments using the practice management software. The introduction of a practice management system for operating medical and healthcare practices during the COVID-19 pandemic has eased the process, as data entering into computerized systems is more convenient than paper-based methods. The upsurge in the demand for achieving efficiency in operations and documentation with nominal errors is boosting the market growth.

Gather more insights about the market drivers, restrains and growth of the Global Practice Management System market

In addition, the rising number of technological developments coupled with the varying dynamics of healthcare/hospital settings have paved ample opportunities for market growth. Moreover, the increasing focus on high-quality care & cost-effective treatment is also anticipated to drive the market growth. Furthermore, a rise in the R&D investments and demand for practice management systems is expected to fuel the market growth over the forecast period. There is high competition between key players, which has prioritized collaborations and partnerships between other companies to enhance the practice management system market.

Moreover, according to the Congressional Research Service report, in 2018, the federal funding for research & development in the U.S. has risen from USD 2.8 billion in 1953 to USD 127.2 billion in 2018. Such factors are driving R&D activities and are expected to support market growth. The growing geriatric population is also expected to propel the market. Elderlies are susceptible to chronic diseases, such as diabetes and cardiovascular diseases, that often lead to hospitalizations. Thus, the increasing geriatric population is expected to increase the patient pool for several chronic diseases. Furthermore, the growing incidences of drug resistance have fueled the demand to maintain & track patient history and medical data.

Browse through Grand View Research’s Healthcare IT Industry Research Reports.

Ambient Assisted Living Market – The global ambient assisted living market size was valued at USD 5.9 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 26.6% from 2023 to 2030.
Surgical Planning Software Market – The global surgical planning software market was valued at USD 102.1 million in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 6.5% from 2023 to 2030.

Practice Management System Market Segmentation

Grand View Research has segmented the global practice management system market on the basis of product, component, delivery mode, end-user, and region:

Practice Management System Product Outlook (Revenue, USD Million, 2017 – 2030)

Integrated
Standalone

Practice Management System Component Outlook (Revenue, USD Million, 2017 – 2030)

Software
Services

Practice Management Systems Delivery Mode Outlook (Revenue, USD Million, 2017 – 2030)

On-premise
Web-based
Cloud-based

Practice Management System End-user Outlook (Revenue, USD Million, 2017 – 2030)

Physician Back Office
Pharmacies
Diagnostic Laboratories
Other Settings

Practice Management System Regional Outlook (Revenue, USD Million, 2017 – 2030)

North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)

Market Share Insights

September 2020: CloudMD Software & Services Inc. acquired the majority of the shares of Benchmark Systems, which is a fully integrated cloud-based healthcare solution provider.
July 2019: Elite Computer Italia, a dental practice management software company, was acquired by Henry Schein to increase its regional presence.

Key Companies profiled:

Some of the prominent players in the global practice management system market include:

Henry Schein, Inc.
Allscripts Healthcare, LLC
AdvantEdge Healthcare Solutions
Athenahealth
Cerner Corporation (Oracle)
Epic Systems Corporation
GE Healthcare
McKesson Corporation
Accumedic Computer Systems, Inc.
NXGN Management, LLC
eClinicalWorks
CoreCloud
Kareo, Inc.
Practice Fusion, Inc.
AdvancedMD, Inc.
DrChrono, Inc.
CollaborateMD Inc.
Greenway Health, LLC
OfficeAlly Inc.
PracticeSuite Inc.

Order a free sample PDF of the Practice Management System Market Intelligence Study, published by Grand View Research.

About Grand View Research

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Cosmetic Surgery And Procedure Market Worth $145.7 Billion By 2030

Cosmetic Surgery and Procedure Industry Overview

The global cosmetic surgery and procedure market size was valued at USD 63.4 billion in 2021 and is projected to exhibit a compound annual growth rate (CAGR) of 9.6% from 2022 to 2030. Manufacturers coming up with innovative aesthetic devices has led to an increased demand for aesthetic treatments in recent years. For instance, the introduction of technologically advanced products, such as non-invasive body contouring systems, which use fat freezing technology, is expected to create lucrative growth opportunities. According to the Aesthetic Society (U.S.), non-invasive body fat reduction was among the top 5 non-invasive procedures in the U.S. in 2020 with 140,314 procedures performed.

The COVID-19 pandemic had significantly affected the aesthetics medicine market. Initially, social distancing and a sudden sharp cut in consumers’ income level had negatively impacted the aesthetics medicine market. The market had witnessed a phase of short-term negative growth owing to factors, such as a decline in product demand, limited operations, temporary closures of beauty centers, and disruption in the manufacturing & supply chain. However, remote working has increased the time spent on Zoom calls. People are paying attention to their physical appearance closely. This has increased the demand for cosmetic surgeries, with Botox being one of the most preferred procedures. Interest in non-invasive procedures has increased during the past few months while interest in invasive procedures has declined.

Gather more insights about the market drivers, restrains and growth of the Global Cosmetic Surgery and Procedure market

Thus, the market has witnessed a spike during the past few months and it is expected to be in high demand throughout the forecasted period. Growing fitness consciousness to look young has increased the demand for aesthetic treatments in developing countries. Aesthetic procedures, such as liposuction, nose reshaping, and Botox injections, are gaining consumer interest in countries, such as India and South Korea. According to the International Society of Aesthetic Plastic Surgery (ISAPS), India was ranked among the top 5 countries performing non-surgical procedures at a global level. This highlights the high growth prospects that lie ahead for aesthetic manufacturers in the country.

Browse through Grand View Research’s Medical Devices Industry Research Reports.

Magnetoencephalography Market – The global magnetoencephalography market size was valued at USD 277.5 million in 2022 and is anticipated to expand at a compound annual growth rate (CAGR) of 5.8% from 2023 to 2030.
Vascular Access Devices Market – The global vascular access devices market size was valued at USD 1.77 billion in 2022 and is anticipated to expand at a compound annual growth rate (CAGR) of 5% from 2023 to 2030.

Cosmetic Surgery And Procedure Market Segmentation

Grand View Research has segmented the cosmetic surgery and procedure market on the basis of procedure type, gender, age group and region

Cosmetic Surgery And Procedure Type Outlook (Revenue, USD Million, 2018 – 2030)

Invasive
- Breast Augmentation
- Liposuction
- Nose Reshaping
- Eyelid Surgery
- Tummy Tuck
- Others
Non-invasive
- Botox Injections
- Soft Tissue Fillers
- Chemical Peel
- Laser Hair Removal
- Microdermabrasion
- Others

Cosmetic Surgery & Procedure Gender Outlook (USD Million, 2018 – 2030)

Male
Female

Cosmetic Surgery & Procedure Age Group Outlook (USD Million, 2018 – 2030)

13-29
30-54
55 and above

Cosmetic Surgery And Procedure Regional Outlook (Revenue, USD Million, 2018 – 2030)

North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)

Key Companies profiled:

Some of the key players in the global cosmetic surgery and procedure market include:

AbbVie
Cynosure
Evolus Inc.
RevanceGalderma
Lumenis
Solta Medical
Syneron Candela
Alma Laser

Order a free sample PDF of the Cosmetic Surgery And Procedure Market Intelligence Study, published by Grand View Research.

About Grand View Research

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com